Dexcom announced today that it’s preparing updates to its two mobile apps that will allow users of its Continuous Glucose Monitor System to track everything straight from Apple Watch. The apps will ...

Dexcom (San Diego, CA) received FDA clearance for its G4 Platinum continuous glucose monitoring system. It includes an under-skin sensor, a wireless transmitter, and the interactive monitor that picks ...

DEXCOM G4 PLATINUM continuous glucose monitor by Dexcom Dexcom announced that the FDA has approved its Dexcom G4 Platinum continuous glucose monitor (CGM) for patients with diabetes. Dexcom announced ...

The US Food and Drug Administration (FDA) has approved a new insulin pump/continuous glucose monitor (CGM) product, Tandem's t:slim Insulin Pump and Dexcom G4 PLATINUM CGM System, according to a ...

Dexcom has received approval from the FDA for a new version of its smartphone connected Dexcom Share platform that will eliminate the docking cradle and allow a patient's continuous glucose monitor ...

SAN DIEGO--(BUSINESS WIRE)--Dexcom (NASDAQ: DXCM), a leader in continuous glucose monitoring, announced today that the U.S. Food and Drug Administration has approved its eagerly anticipated new ...

The Julphar revolutionary real-time continuous glucose monitoring device (CGM), DEXCOM G4 PLATINUM is now available in UAE, KSA, Kuwait and Oman and will soon be available in Qatar, Bahrain and ...

New products in development with partners Johnson & Johnson and Tandem could help Dexcom outmaneuver its chief competitor, Medtronic. More than 365 million people have diabetes worldwide and estimates ...

The future is closer than you think, at least in medical devices. I remember as a kid watching a science fiction movie where the patient was lying in a room and the doctor walked in, waved a device ...

European Union regulators have cleared for sale an insulin pump for diabetics made by Johnson & Johnson that works off a continuous glucose monitor made by DexCom of San Diego, Johnson & Johnson said ...

As med tech outfits race to develop innovative, noninvasive technology for diabetes monitoring, Dexcom ($DXCM) snagged FDA approval for a new artificial pancreas ...